Business Description
Gulf Pharmaceutical Industries PSC
ISIN : AEG000201018
Total Employee Number:
1,968Compare
Compare
Traded in other countries / regions
JULPHAR.United Arab Emirates IPO Date
2002-10-20Description
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.52 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 2.05 | |||||
Interest Coverage | 3.9 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.15 | |||||
Beneish M-Score | -2.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -12.7 | |||||
3-Year EBITDA Growth Rate | -3.2 | |||||
3-Year Book Growth Rate | 1.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.05 | |||||
9-Day RSI | 51.92 | |||||
14-Day RSI | 49.37 | |||||
6-1 Month Momentum % | -10.34 | |||||
12-1 Month Momentum % | -27.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.86 | |||||
Quick Ratio | 2.13 | |||||
Cash Ratio | 0.48 | |||||
Days Inventory | 216.27 | |||||
Days Sales Outstanding | 179.83 | |||||
Days Payable | 172.18 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.15 | |||||
Operating Margin % | 5.94 | |||||
Net Margin % | 5.76 | |||||
EBITDA Margin % | 11.62 | |||||
FCF Margin % | 7.57 | |||||
OCF Margin % | 11.51 | |||||
ROE % | 6.93 | |||||
ROA % | 3.53 | |||||
ROIC % | 5.31 | |||||
3-Year ROIIC % | -13.61 | |||||
ROC (Joel Greenblatt) % | 7.81 | |||||
ROCE % | 5.86 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.93 | |||||
Forward PE Ratio | 13 | |||||
PE Ratio without NRI | 20.8 | |||||
Price-to-Owner-Earnings | 35 | |||||
PS Ratio | 1.04 | |||||
PB Ratio | 1.23 | |||||
Price-to-Tangible-Book | 1.28 | |||||
Price-to-Free-Cash-Flow | 13.87 | |||||
Price-to-Operating-Cash-Flow | 9.12 | |||||
EV-to-EBIT | 15.14 | |||||
EV-to-EBITDA | 9.16 | |||||
EV-to-Revenue | 1.06 | |||||
EV-to-FCF | 14.2 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Price-to-Median-PS-Value | 0.53 | |||||
Price-to-Graham-Number | 1.08 | |||||
| Price-to-Net-Current-Asset-Value | 1.76 | |||||
Earnings Yield (Greenblatt) % | 6.6 | |||||
FCF Yield % | 7.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gulf Pharmaceutical Industries PSC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil د.إ) | 1,150.6 | ||
| EPS (TTM) (د.إ) | 0.058 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.27 | ||
| 3-Year Sortino Ratio | 0.76 | ||
| Volatility % | 23.2 | ||
| 14-Day RSI | 49.37 | ||
| 14-Day ATR (د.إ) | 0.024253 | ||
| 20-Day SMA (د.إ) | 1.0315 | ||
| 12-1 Month Momentum % | -27.27 | ||
| 52-Week Range (د.إ) | 0.99 - 1.49 | ||
| Shares Outstanding (Mil) | 1,155.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gulf Pharmaceutical Industries PSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gulf Pharmaceutical Industries PSC Stock Events
| Event | Date | Price (د.إ) | ||
|---|---|---|---|---|
| 0.565581:1 Stock Split | 2020-05-19 | 1.28 (+0.00%) | ||
| 1.03:1 Stock Split | 2018-05-03 | 3.59 (+1.74%) | ||
| 1.03:1 Stock Split | 2017-04-25 | 3.72 (+3.31%) | ||
| 1.04:1 Stock Split | 2016-05-08 | 3.43 (+0.00%) | ||
| 1.05:1 Stock Split | 2015-05-07 | 4.09 (-2.28%) | ||
| 1.1:1 Stock Split | 2014-04-17 | 4.58 (+0.27%) | ||
| 1.1:1 Stock Split | 2013-03-28 | 3.38 (+0.00%) | ||
| 1.1:1 Stock Split | 2012-04-26 | 3.13 (+0.00%) |
Show
Entries
Gulf Pharmaceutical Industries PSC Frequently Asked Questions
What is Gulf Pharmaceutical Industries PSC(ADX:JULPHAR)'s stock price today?
The current price of ADX:JULPHAR is د.إ1.04. The 52 week high of ADX:JULPHAR is د.إ1.49 and 52 week low is د.إ0.99.
When is next earnings date of Gulf Pharmaceutical Industries PSC(ADX:JULPHAR)?
The next earnings date of Gulf Pharmaceutical Industries PSC(ADX:JULPHAR) is .
Does Gulf Pharmaceutical Industries PSC(ADX:JULPHAR) pay dividends? If so, how much?
Gulf Pharmaceutical Industries PSC(ADX:JULPHAR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gulf Pharmaceutical Industries PSC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers